Salivary gland tumor pathophysiology: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 20: Line 20:
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Pleomorphic adenoma
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Pleomorphic adenoma
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Variable
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Variable
| style="padding: 5px 5px; background: #F5F5F5;" |mixed proportion; must include:  
| style="padding: 5px 5px; background: #DCDCDC; |mixed proportion; must include:  
*myoepithelium
*myoepithelium
*mesenchymal stroma
*mesenchymal stroma
*epithelium (ductal cells) or
*epithelium (ductal cells) or
*chondromyxoid stroma
*chondromyxoid stroma
| style="padding: 5px 5px; background: #F5F5F5;" |Variable
| style="padding: 5px 5px; background: #DCDCDC; |Variable
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Variable
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Variable
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Plasmacytoid
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Plasmacytoid
Line 33: Line 33:
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Warthin tumor
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Warthin tumor
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Papillary, bilayer
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Papillary, bilayer
| style="padding: 5px 5px; background: #F5F5F5;" |Cuboid (basal), columnar (apical)
| style="padding: 5px 5px; background: #DCDCDC; |Cuboid (basal), columnar (apical)
| style="padding: 5px 5px; background: #F5F5F5;" |Clearly seen
| style="padding: 5px 5px; background: #DCDCDC; |Clearly seen
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Eosinophilic, abundant
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Eosinophilic, abundant
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Unremarkable
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Unremarkable
Line 42: Line 42:
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Basal cell adenoma
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Basal cell adenoma
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |variable, islands surrounded by hyaline bands, lesion encapsulated
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |variable, islands surrounded by hyaline bands, lesion encapsulated
| style="padding: 5px 5px; background: #F5F5F5;" |Basaloid
| style="padding: 5px 5px; background: #DCDCDC; |Basaloid
| style="padding: 5px 5px; background: #F5F5F5;" |Subtle
| style="padding: 5px 5px; background: #DCDCDC; |Subtle
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Scant, hyperchromatic
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Scant, hyperchromatic
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Granular
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Granular
Line 51: Line 51:
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Canalicular adenoma
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Canalicular adenoma
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Chains of cells
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Chains of cells
| style="padding: 5px 5px; background: #F5F5F5;" |Cuboid or columnar
| style="padding: 5px 5px; background: #DCDCDC; |Cuboid or columnar
| style="padding: 5px 5px; background: #F5F5F5;" |Subtle
| style="padding: 5px 5px; background: #DCDCDC; |Subtle
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Scant, hyperchromatic
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Scant, hyperchromatic
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Granular
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Granular
Line 60: Line 60:
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Sialoblastoma
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Sialoblastoma
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |variable, islands surrounded by loose fibrous stroma
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |variable, islands surrounded by loose fibrous stroma
| style="padding: 5px 5px; background: #F5F5F5;" |Basaloid
| style="padding: 5px 5px; background: #DCDCDC; |Basaloid
| style="padding: 5px 5px; background: #F5F5F5;" |Subtle
| style="padding: 5px 5px; background: #DCDCDC; |Subtle
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Scant, hyperchromatic
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Scant, hyperchromatic
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Granular
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Granular
Line 68: Line 68:
|-
|-
|}
|}
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 04:00, 8 November 2015

Salivary gland tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Salivary gland tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Fine-needle Aspiration Biopsy (FNAB)

Head X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Salivary gland tumor pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Salivary gland tumor pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Salivary gland tumor pathophysiology

CDC on Salivary gland tumor pathophysiology

Salivary gland tumor pathophysiology in the news

Blogs on Salivary gland tumor pathophysiology

Directions to Hospitals Treating Salivary gland tumor

Risk calculators and risk factors for Salivary gland tumor pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

The pathophysiology of salivary gland tumors depends on the histological subtype.

Pathophysiology
Entity Architecture Morphology Cell borders Cytoplasm Nucleus Differential Diagnosis Other
Pleomorphic adenoma Variable mixed proportion; must include:
  • myoepithelium
  • mesenchymal stroma
  • epithelium (ductal cells) or
  • chondromyxoid stroma
 Variable Variable Plasmacytoid Adenoid cystic carcinoma Occasionally encapsulated, mixed proportion of glandular, myoepithelial and mesenchymal cells
Warthin tumor Papillary, bilayer Cuboid (basal), columnar (apical) Clearly seen Eosinophilic, abundant Unremarkable Sebaceous lymphadenoma AKA papillary cystadenoma lymphomatosum
Basal cell adenoma variable, islands surrounded by hyaline bands, lesion encapsulated Basaloid Subtle Scant, hyperchromatic Granular Basal cell adenocarcinoma
Canalicular adenoma Chains of cells Cuboid or columnar Subtle Scant, hyperchromatic Granular Basal cell adenoma Exclusively oral cavity, 80% in upper lip; immunohistochemistry: p63-
Sialoblastoma variable, islands surrounded by loose fibrous stroma Basaloid Subtle Scant, hyperchromatic Granular Adenoid cystic carcinoma Basal cell adenocarcinoma

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Salivary_gland_tumor_pathophysiology&oldid=1184622"